Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future DirectionsNuno Jorge Lamas, Paul Hofman, Adam Macocco et al.|Cancers|2021Cited by 62
Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohortNuno Jorge Lamas, Paul Hofman, Sandra Lassalle et al.|Pathology|2023Cited by 10